In clinical supply, waste often reflects the price of certainty. Unpredictable enrollment, complex dosing and regulatory constraints all have a negative impact. To manage these factors, organizations default to high overage and rigid buffers—which often create even more waste.
But waste reduction is not just a cost-saving exercise. It’s a strategic lever.
This white paper explores the following:
- Why waste reduction is a lever for agility, fulfillment and trial scalability
- Where and why waste occurs across the supply chain
- How organizations define and measure waste—and why a more nuanced definition is essential
- Three proven strategies to reduce waste without compromising fulfillment
Add insights to your inbox
We’ll send you content you’ll want to read – and put to use.
